Please assess the completion status of the following clinical trial:

Trial Title: Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* diagnosis of primary peritoneal carcinoma, fallopian tube epithelial ovarian carcinoma,~* stage III suboptimal surgery or biopsy,~* stage IV disease~* no prior chemotherapy~Exclusion Criteria:~* unstable heart conditions~* high blood pressure~* vascular disorders~* bleeding problems

- Gender: FEMALE
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- I (Type: EXPERIMENTAL): This is a single Arm study. Two of the study drugs used are non-experimental. One of the study drugs is experimental.

Based on this trial design, predict the completion outcome and termination type (if applicable).